Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
Crossref DOI link: https://doi.org/10.1186/s12943-023-01754-6
Published Online: 2023-03-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Ho Jin
Pham, Phuong Chi
Hyun, Seung Yeob
Baek, Byungyeob
Kim, Byungjin
Kim, Yunha
Min, Hye-Young
Lee, Jeeyeon
Lee, Ho-Young
Text and Data Mining valid from 2023-03-08
Version of Record valid from 2023-03-08
Article History
First Online: 8 March 2023